{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:39:59Z","timestamp":1793619599548,"version":"4.5.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG061165"],"award-info":[{"award-number":["R01AG061165"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG06828"],"award-info":[{"award-number":["R01AG06828"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.intimp.2021.107806","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T08:33:26Z","timestamp":1621845206000},"page":"107806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis"],"prefix":"10.1016","volume":"98","author":[{"given":"Durai","family":"Sellegounder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Zafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1217-2059","authenticated-orcid":false,"given":"Misagh","family":"Rajabinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3516-0130","authenticated-orcid":false,"given":"Mahdi","family":"Taghadosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Kapahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10223","key":"10.1016\/j.intimp.2021.107806_b0005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China. Lancet."},{"issue":"10223","key":"10.1016\/j.intimp.2021.107806_b0010","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2021.107806_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107694","article-title":"Mesenchymal stromal\/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities","volume":"97","author":"Moradinasab","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-02902-w","article-title":"Clinical determinants for fatality of 44,672 patients with COVID-19","volume":"24","author":"Deng","year":"2020","journal-title":"Crit care."},{"issue":"7821","key":"10.1016\/j.intimp.2021.107806_b0025","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2021.107806_b0030","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMp2006761","article-title":"Covid-19 and immunity in aging populations\u2014a new research agenda","volume":"383","author":"Koff","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"Suppl_1","key":"10.1016\/j.intimp.2021.107806_b0035","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.intimp.2021.107806_b0040","first-page":"1","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2021.107806_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2020.06.002","article-title":"Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes","volume":"54","author":"Bonaf\u00e8","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.intimp.2021.107806_b0050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","article-title":"The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality","volume":"28","author":"Chaudhuri","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2021.107806_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102833","article-title":"Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients","volume":"57","author":"Wang","year":"2020","journal-title":"EBioMedicine."},{"key":"10.1016\/j.intimp.2021.107806_b0060","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-med-041316-085215","article-title":"Targeting RAGE signaling in inflammatory disease","volume":"69","author":"Hudson","year":"2018","journal-title":"Annu. Rev. Med."},{"issue":"2","key":"10.1016\/j.intimp.2021.107806_b0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.it.2018.12.007","article-title":"Metabolic alterations in aging macrophages: ingredients for inflammaging?","volume":"40","author":"van Beek","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2021.107806_b0070","article-title":"The Receptor for Advanced Glycation End Product (RAGE) Pathway in COVID-19","volume":"1\u201317","author":"Yalcin Kehribar","year":"2020","journal-title":"Biomarkers"},{"key":"10.1016\/j.intimp.2021.107806_b0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2017.02.030","article-title":"Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases","volume":"177","author":"Byun","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2021.107806_b0080","article-title":"Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives","volume":"119251","author":"Chiappalupi","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13613-021-00836-2","article-title":"Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality","volume":"11","author":"Lim","year":"2021","journal-title":"Ann. Intensive Care."},{"issue":"9","key":"10.1016\/j.intimp.2021.107806_b0090","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/gerona\/glq074","article-title":"Does accumulation of advanced glycation end products contribute to the aging phenotype?","volume":"65","author":"Semba","year":"2010","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2021.107806_b0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/pr.2013.243","article-title":"Methylglyoxal concentrations differ in standard and washed neonatal packed red blood cells","volume":"75","author":"Kiefer","year":"2014","journal-title":"Pediatr. Res."},{"issue":"21","key":"10.1016\/j.intimp.2021.107806_b0100","doi-asserted-by":"crossref","first-page":"14987","DOI":"10.1016\/S0021-9258(18)42137-0","article-title":"Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface","volume":"267","author":"Schmidt","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2021.107806_b0105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.tibs.2011.08.008","article-title":"RAGE: a single receptor fits multiple ligands","volume":"36","author":"Fritz","year":"2011","journal-title":"Trends Biochem. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2021.107806_b0110","doi-asserted-by":"crossref","first-page":"19891","DOI":"10.3390\/ijms141019891","article-title":"Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond","volume":"14","author":"Daffu","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2021.107806_b0115","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jiph.2020.07.014","article-title":"COVID-19 and comorbidities: Deleterious impact on infected patients","volume":"13","author":"Ejaz","year":"2020","journal-title":"J. Infect. Public Health."},{"issue":"20","key":"10.1016\/j.intimp.2021.107806_b0120","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.intimp.2021.107806_b0125","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10719-016-9704-0","article-title":"Advanced glycation in diabetes, aging and age-related diseases: editorial and dedication","volume":"33","author":"Monnier","year":"2016","journal-title":"Glycoconj J."},{"issue":"10","key":"10.1016\/j.intimp.2021.107806_b0130","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/j.1532-5415.2009.02438.x","article-title":"Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults","volume":"57","author":"Semba","year":"2009","journal-title":"J. Am. Geriatr. Soc."},{"issue":"9","key":"10.1016\/j.intimp.2021.107806_b0135","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/gerona\/glq074","article-title":"Does accumulation of advanced glycation end products contribute to the aging phenotype?","volume":"65","author":"Semba","year":"2010","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.intimp.2021.107806_b0140","article-title":"RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection?","volume":"144","author":"Kerkeni","year":"2020","journal-title":"Med. Hypotheses. Med. Hypotheses."},{"issue":"7","key":"10.1016\/j.intimp.2021.107806_b0145","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00011-020-01353-x","article-title":"SARS-CoV-2-mediated inflammatory response in lungs: should we look at RAGE?","volume":"69","author":"Rojas","year":"2020","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2021.107806_b0150","first-page":"1","article-title":"Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China","author":"Ran","year":"2020","journal-title":"Hypertens Res."},{"issue":"10229","key":"10.1016\/j.intimp.2021.107806_b0155","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.intimp.2021.107806_b0160","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/jm00136a001","article-title":"Inhibition of the renin-angiotensin system. A new approach to the therapy of hypertension","volume":"24","author":"Ondetti","year":"1981","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2021.107806_b0165","first-page":"1602","article-title":"ACE2 variants underlie interindividual variability and susceptibility to COVID-19 in Italian population","volume":"28","author":"Renieri","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2021.107806_b0170","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme\u2013related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2021.107806_b0175","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/256294","article-title":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease","volume":"2012","author":"Tikellis","year":"2012","journal-title":"Int. J. Peptides."},{"issue":"21","key":"10.1016\/j.intimp.2021.107806_b0180","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1007\/s00018-004-4240-7","article-title":"Angiotensin-converting enzyme-2: a molecular and cellular perspective","volume":"61","author":"Warner","year":"2004","journal-title":"Cellular Mol. Life Sci.: CMLS."},{"issue":"7798","key":"10.1016\/j.intimp.2021.107806_b0185","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2021.107806_b0190","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.25011\/cim.v35i5.18701","article-title":"Advanced glycation end-products activate the renin-angiotensin system through the RAGE\/PI3-K signaling pathway in podocytes","author":"Cheng","year":"2012","journal-title":"Clin. Invest. Med."},{"issue":"20","key":"10.1016\/j.intimp.2021.107806_b0195","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1016\/j.febslet.2005.06.058","article-title":"Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression","volume":"579","author":"Yamagishi","year":"2005","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12013-007-0039-0","article-title":"Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications","volume":"49","author":"Vasdev","year":"2007","journal-title":"Cell Biochem. Biophys."},{"issue":"9","key":"10.1016\/j.intimp.2021.107806_b0205","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41440-020-0488-z","article-title":"SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs\/ARBs","volume":"43","author":"Ciulla","year":"2020","journal-title":"Hypertens. Res."},{"issue":"25","key":"10.1016\/j.intimp.2021.107806_b0210","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of Covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6508","key":"10.1016\/j.intimp.2021.107806_b0215","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.intimp.2021.107806_b0220","doi-asserted-by":"crossref","unstructured":"C. Eleazu, N. Omar, O.Z. Lim, B.S. Yeoh, N.H. Nik Hussain, M. Mohamed, Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea? Frontiers in physiology. 2019;10:787-.","DOI":"10.3389\/fphys.2019.00787"},{"key":"10.1016\/j.intimp.2021.107806_b0225","first-page":"1","article-title":"Obesity as a risk factor for COVID-19: an overview","author":"Alberca","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"11","key":"10.1016\/j.intimp.2021.107806_b0230","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13128","article-title":"Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships","volume":"21","author":"Popkin","year":"2020","journal-title":"Obes. Rev."},{"key":"10.1016\/j.intimp.2021.107806_b0235","first-page":"2","article-title":"Associations between body-mass index with severity of SARS-CoV-2 infection in a community-based cohort of 6.9 million people in England","author":"Gao","year":"2021","journal-title":"Lancet Diabet. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-2833-7","article-title":"Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan","volume":"24","author":"Shi","year":"2020","journal-title":"Crit Care."},{"issue":"7","key":"10.1016\/j.intimp.2021.107806_b0245","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S2213-8587(20)30160-1","article-title":"Prevalence of obesity among adult inpatients with COVID-19 in France","volume":"8","author":"Caussy","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107806_b0250","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2337\/db11-1116","article-title":"Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: involvement of Toll-like receptor 2","volume":"62","author":"Monden","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0255","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/21623945.2020.1817278","article-title":"RAGE signalling in obesity and diabetes: focus on the adipose tissue macrophage","volume":"9","author":"Feng","year":"2020","journal-title":"Adipocyte."},{"issue":"6","key":"10.1016\/j.intimp.2021.107806_b0260","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.2337\/db13-1636","article-title":"RAGE regulates the metabolic and inflammatory response to high-fat feeding in mice","volume":"63","author":"Song","year":"2014","journal-title":"Diabetes"},{"issue":"28","key":"10.1016\/j.intimp.2021.107806_b0265","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1021\/acs.jafc.0c03286","article-title":"Dietary Genistein Reduces Methylglyoxal and Advanced Glycation End Product Accumulation in Obese Mice Treated with High-Fat Diet","volume":"68","author":"Zhao","year":"2020","journal-title":"J Agric Food Chem."},{"issue":"6","key":"10.1016\/j.intimp.2021.107806_b0270","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/ATVBAHA.113.302281","article-title":"N\u03b5-(carboxymethyl) lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance","volume":"34","author":"Gaens","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2021.107806_b0275","first-page":"1","article-title":"COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nature Reviews","author":"Lim","year":"2020","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.intimp.2021.107806_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.07.007","article-title":"Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1\u03b1\/glycolysis-dependent axis","volume":"32","author":"Codo","year":"2020","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0285","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/S2666-7568(20)30033-7","article-title":"Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis","volume":"2","author":"Bramante","year":"2021","journal-title":"The Lancet Healthy Longevity."},{"issue":"3","key":"10.1016\/j.intimp.2021.107806_b0290","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4093\/dmj.2017.0105","article-title":"The role of advanced glycation end products in diabetic vascular complications","volume":"42","author":"Rhee","year":"2018","journal-title":"Diabetes & Metabol. J."},{"issue":"2","key":"10.1016\/j.intimp.2021.107806_b0295","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jdi.12391","article-title":"Genetics of cardiovascular and renal complications in diabetes","volume":"7","author":"Ma","year":"2016","journal-title":"J. Diabetes Investig."},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","article-title":"Advanced glycation end products and diabetic complications","volume":"18","author":"Singh","year":"2014","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0305","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging: an evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann. NY Acad. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0310","first-page":"1","article-title":"SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2021.107806_b0315","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1159\/000490818","article-title":"Emerging role of high mobility group box-1 in thrombosis-related diseases","volume":"47","author":"Wu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"10","key":"10.1016\/j.intimp.2021.107806_b0320","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune\u2013metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.intimp.2021.107806_b0325","first-page":"401","article-title":"The aging process and potential interventions to extend life expectancy","volume":"2","author":"Tosato","year":"2007","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.intimp.2021.107806_b0330","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression","volume":"5","author":"Copp\u00e9","year":"2010","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0335","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1083\/jcb.201708092","article-title":"Senescence and aging: Causes, consequences, and therapeutic avenues","volume":"217","author":"McHugh","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.intimp.2021.107806_b0340","doi-asserted-by":"crossref","unstructured":"J. Nehme, M. Borghesan, S. Mackedenski, T.G. Bird, M. Demaria, Cellular senescence as a potential mediator of COVID\u201019 severity in the elderly. Aging Cell. 19, 10, e13237.","DOI":"10.1111\/acel.13237"},{"issue":"8","key":"10.1016\/j.intimp.2021.107806_b0345","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.18632\/aging.103001","article-title":"COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?","volume":"12","author":"Sargiacomo","year":"2020","journal-title":"Aging (Albany NY)."},{"issue":"25","key":"10.1016\/j.intimp.2021.107806_b0350","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","article-title":"Severe Covid-19","volume":"383","author":"Berlin","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-018-0202-y","article-title":"Biomarkers for acute respiratory distress syndrome and prospects for personalised medicine","volume":"16","author":"Spadaro","year":"2019","journal-title":"J. Inflamm. (Lond)."},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"10","key":"10.1016\/j.intimp.2021.107806_b0365","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00134-012-2624-y","article-title":"The receptor for advanced glycation end products and acute lung injury\/acute respiratory distress syndrome","volume":"38","author":"Guo","year":"2012","journal-title":"Intensive Care Med."},{"issue":"11","key":"10.1016\/j.intimp.2021.107806_b0370","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1164\/rccm.201201-0003OC","article-title":"Inflammasome-regulated cytokines are critical mediators of acute lung injury","volume":"185","author":"Dolinay","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2021.107806_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.jss.2009.11.125","article-title":"Diet high in advanced glycation end products exacerbates pulmonary inflammatory response and impairs lung compliance in mice following gastric aspiration","author":"Ottosen","year":"20101582214","journal-title":"J. Surg. Res."},{"issue":"7","key":"10.1016\/j.intimp.2021.107806_b0380","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2021.107806_b0385","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3389\/fimmu.2020.01518","article-title":"Targeting the NLRP3 inflammasome in severe COVID-19","volume":"11","author":"Freeman","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.107806_b0390","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3389\/fimmu.2020.01580","article-title":"Severe COVID-19: NLRP3 inflammasome dysregulated","volume":"11","author":"van den Berg","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0395","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00011-020-01413-2","article-title":"Inflammasome formation in the lungs of patients with fatal COVID-19","volume":"70","author":"Toldo","year":"2021","journal-title":"Inflamm. Res."},{"issue":"10","key":"10.1016\/j.intimp.2021.107806_b0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-2021-3","article-title":"Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1\/RAGE\/cathespin B signaling pathway and NLRP3 inflammasome activation","volume":"10","author":"Jia","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2021.107806_b0405","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jnutbio.2016.09.014","article-title":"Long-term administration of advanced glycation end-product stimulates the activation of NLRP3 inflammasome and sparking the development of renal injury","volume":"39","author":"Yeh","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.intimp.2021.107806_b0410","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.31.1_supplement.lb194","article-title":"Modulation of inflammasome signaling by advanced glycation end products (AGEs)","volume":"31","author":"Son","year":"2017","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.intimp.2021.107806_b0415","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/cc6184","article-title":"Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection","volume":"11","author":"Lutterloh","year":"2007","journal-title":"Crit. Care"},{"key":"10.1016\/j.intimp.2021.107806_b0420","doi-asserted-by":"crossref","first-page":"9570616","DOI":"10.1155\/2019\/9570616","article-title":"Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes","volume":"2019","author":"Yang","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"issue":"6","key":"10.1016\/j.intimp.2021.107806_b0425","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.diabet.2020.07.006","article-title":"Metformin and COVID-19: From cellular mechanisms to reduced mortality","volume":"46","author":"Scheen","year":"2020","journal-title":"Diabetes Metab."},{"issue":"9","key":"10.1016\/j.intimp.2021.107806_b0430","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","article-title":"COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives","volume":"17","author":"Nishiga","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"6","key":"10.1016\/j.intimp.2021.107806_b0435","doi-asserted-by":"crossref","first-page":"H2587","DOI":"10.1152\/ajpheart.00516.2003","article-title":"Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart","volume":"285","author":"Liu","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2021.107806_b0440","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1073\/pnas.98.3.1171","article-title":"A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys","volume":"98","author":"Vaitkevicius","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.intimp.2021.107806_b0445","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2337\/diabetes.53.7.1813","article-title":"Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis","volume":"53","author":"Forbes","year":"2004","journal-title":"Diabetes"},{"issue":"13","key":"10.1016\/j.intimp.2021.107806_b0450","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/hc3801.097806","article-title":"Improved arterial compliance by a novel advanced glycation end-product crosslink breaker","volume":"104","author":"Kass","year":"2001","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.intimp.2021.107806_b0455","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1745-7254.2005.00240.x","article-title":"C16, a novel advanced glycation endproduct breaker, restores cardiovascular dysfunction in experimental diabetic rats","volume":"26","author":"Cheng","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.intimp.2021.107806_b0460","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2362.2006.01672.x","article-title":"Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes","volume":"36","author":"Chang","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0465","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1756-185X.2011.01679.x","article-title":"Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis","volume":"15","author":"Syngle","year":"2012","journal-title":"Int. J. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.intimp.2021.107806_b0470","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41577-020-0407-1","article-title":"Tissue damage from neutrophil-induced oxidative stress in COVID-19","volume":"20","author":"Laforge","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2021.107806_b0475","article-title":"Acute Renal Failure in Critically Ill COVID-19 Patients With a Focus on the Role of Renal Replacement Therapy: A Review of What We Know So Far","volume":"12","author":"Raza","year":"2020","journal-title":"Cureus."},{"issue":"9","key":"10.1016\/j.intimp.2021.107806_b0480","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.2337\/db12-1608","article-title":"DNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathy","volume":"62","author":"Kaida","year":"2013","journal-title":"Diabetes"},{"issue":"13","key":"10.1016\/j.intimp.2021.107806_b0485","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0047-6374(01)00272-X","article-title":"Carnosine, the anti-ageing, anti-oxidant dipeptide, may react with protein carbonyl groups","volume":"122","author":"Hipkiss","year":"2001","journal-title":"Mech. Ageing Dev."},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0490","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1021\/jf980780j","article-title":"Ability of carnosine and other skeletal muscle components to quench unsaturated aldehydic lipid oxidation products","volume":"47","author":"Zhou","year":"1999","journal-title":"J. Agric. Food Chem."},{"issue":"5","key":"10.1016\/j.intimp.2021.107806_b0495","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/1541-4337.12376","article-title":"The inhibition of advanced glycation end products by carnosine and other natural dipeptides to reduce diabetic and age-related complications","volume":"17","author":"Freund","year":"2018","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"issue":"5","key":"10.1016\/j.intimp.2021.107806_b0500","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s10495-014-0974-3","article-title":"LR-90 prevents methylglyoxal-induced oxidative stress and apoptosis in human endothelial cells","volume":"19","author":"Figarola","year":"2014","journal-title":"Apoptosis"},{"issue":"8","key":"10.1016\/j.intimp.2021.107806_b0505","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41423-020-0485-9","article-title":"The ORF3a protein of SARS-CoV-2 induces apoptosis in cells","volume":"17","author":"Ren","year":"2020","journal-title":"Cell Mol. Immunol."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2021.107806_b0510","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12013-007-0021-x","article-title":"Novel inhibitors of glycation and AGE formation","volume":"48","author":"Rahbar","year":"2007","journal-title":"Cell Biochem. Biophys."},{"issue":"17","key":"10.1016\/j.intimp.2021.107806_b0515","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1021\/acs.jmedchem.7b00058","article-title":"Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective","volume":"60","author":"Bongarzone","year":"2017","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.intimp.2021.107806_b0520","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1212\/WNL.0000000000000364","article-title":"Clinical trial of an inhibitor of RAGE-Abeta interactions in Alzheimer disease","volume":"82","author":"Galasko","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.intimp.2021.107806_b0525","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2377-14-12","article-title":"Effect of TTP488 in patients with mild to moderate Alzheimer's disease","volume":"14","author":"Burstein","year":"2014","journal-title":"BMC Neurol."},{"issue":"9","key":"10.1016\/j.intimp.2021.107806_b0530","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41423-020-0492-x","article-title":"Elevated serum levels of S100A8\/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients","volume":"17","author":"Chen","year":"2020","journal-title":"Cell Mol. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2021.107806_b0535","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI58642","article-title":"A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease","volume":"122","author":"Deane","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2021.107806_b0540","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejmech.2014.03.072","article-title":"Pyrazole-5-carboxamides, novel inhibitors of receptor for advanced glycation end products (RAGE)","volume":"79","author":"Han","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.intimp.2021.107806_b0545","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.bmc.2015.05.022","article-title":"6-Phenoxy-2-phenylbenzoxazoles, novel inhibitors of receptor for advanced glycation end products (RAGE)","volume":"23","author":"Choi","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2021.107806_b0550","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ejcn.2012.220","article-title":"Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review","volume":"67","author":"Kellow","year":"2013","journal-title":"Eur. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.intimp.2021.107806_b0555","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00726-010-0776-z","article-title":"Health effects of dietary Maillard reaction products: the results of ICARE and other studies","volume":"42","author":"Tessier","year":"2012","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.intimp.2021.107806_b0560","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00726-011-1107-8","article-title":"Study of the urinary and faecal excretion of N \u03b5-carboxymethyllysine in young human volunteers","volume":"43","author":"Delgado-Andrade","year":"2012","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.intimp.2021.107806_b0565","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1755-5922.2010.00177.x","article-title":"Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects","volume":"30","author":"Tahara","year":"2012","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.intimp.2021.107806_b0570","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.arr.2018.06.005","article-title":"Dietary advanced glycation end products and their relevance for human health","volume":"47","author":"Nowotny","year":"2018","journal-title":"Ageing Res. Rev."},{"issue":"7","key":"10.1016\/j.intimp.2021.107806_b0575","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.2337\/diabetes.51.7.2082","article-title":"Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db\/db mouse","volume":"51","author":"Hofmann","year":"2002","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.intimp.2021.107806_b0580","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.ki.5002162","article-title":"Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model","volume":"71","author":"Feng","year":"2007","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.intimp.2021.107806_b0585","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2353\/ajpath.2008.080152","article-title":"Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan","volume":"173","author":"Cai","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2021.107806_b0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.jada.2010.03.018","article-title":"Advanced glycation end products in foods and a practical guide to their reduction in the diet","volume":"110","author":"Uribarri","year":"2010","journal-title":"J. Am. Diet. Assoc."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921004422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921004422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:24:29Z","timestamp":1747308269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921004422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":118,"alternative-id":["S1567576921004422"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107806","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107806"}}